Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9951043 Therapeutic compounds

Patent 9951043 was granted and assigned to Gilead Sciences on April, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Gilead Sciences
Gilead Sciences
Date Filed
February 28, 2014
Date of Patent
April 24, 2018
Patent Applicant
Gilead Sciences
Gilead Sciences
Patent Application Number
14771779
Patent Citations Received
‌
US Patent 12077537 Capsid inhibitors for the treatment of HIV
0
‌
US Patent 11787825 Therapeutic compounds for HIV virus infection
‌
US Patent 11833143 Choline salt forms of an HIV capsid inhibitor
0
‌
US Patent 11944611 Capsid inhibitors for the treatment of HIV
0
‌
US Patent 11993583 Therapeutic compounds
0
‌
US Patent 11760746 Methods and intermediates for preparing therapeutic compounds
‌
US Patent 12122765 Methods and intermediates for preparing therapeutic compounds
0
‌
US Patent 12084467 Therapeutic compounds for HIV virus infection
0
‌
US Patent 11685728 Capsid inhibitors for the prevention of HIV
0
‌
US Patent 11680064 Capsid inhibitors for the treatment of HIV
0
•••
Patent Inventor Names
John O. Link
0
Chien-hung Chou
0
Eda Canales
0
Gediminas Brizgys
0
Jennifer R. Zhang
0
John R. Somoza
0
Michael Graupe
0
Qi Liu
0
Randall L. Halcomb
0
Roland D. Saito
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9951043
Patent Primary Examiner
‌
Matthew P Coughlin

Find more entities like US Patent 9951043 Therapeutic compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo